Dipyridamole administration at the end of an insufficient exercise Tc-99m MIBI SPECT improves detection of multivessel coronary artery disease in patients with previous myocardial infarction

American Journal of Cardiology

Volumn 85, Issue 5, 2000, Pages 532-535

  Candell Riera, Jaume ^a   Santana Boado, César ^a   Castell Conesa, Joan ^a   Aguadé Bruix, Santiago ^a   Bermejo Fraile, Begoña ^a   Soler Soler, Jordi ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; VASODILATOR AGENT;

ARTICLE; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; EXERCISE TEST; FEMALE; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CASE-CONTROL STUDIES; CORONARY DISEASE; DIPYRIDAMOLE; EXERCISE TEST; FEMALE; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS;

EID: 0034151205     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00806-1     Document Type: Article

References (27)

1. 99mTc-MIBI SPECT: improved diagnostic yield in coronary artery disease. J Am Coll Cardiol 1997;29:531-536.
2. Comittee on Advanced Cardiac Imaging and Technology, Council on Clinical Cardiology, American Heart Association, Cardiovascular Imaging Committee, American College of Cardiology; and Board of Directors, Cardiovascular Council, Society of Nuclear Medicine. Standardization of cardiac tomographic imaging. Circulation 1992;86:338-339.
3. Van Train KF, García EV, Maddahi J, Areeda J, Cooke CD, Kiat H, Silagan G, Folks R, Friedman J, Matzer L, Germano G, Bateman T, Ziffer J, DePuey EG, Fink-Bennett D, Cloninger, Berman DS. Multicenter trial validation for quantitative analysis of same-day rest-stress technetium-99 m-sestamibi myocardial tomograms. J Nucl Med 1994;35:609-618.
4. Hockings B, Saltissi S, Croft DN, Webb-Peploe MM. Effect of beta adrenergic blockade on thallium-201 myocardial perfusion imaging. Br Heart J 1983;49:83-89.
5. Martin GJ, Henkin RE, Scanlon PJ. Beta blockers and the sensitivity of the thallium treadmill test. Chest 1987;92:486-487.
6. Brown KA, Rowen M. Impact of antianginal medications, peak heart rate and stress level on the prognostic value of a normal exercise myocardial perfusion imaging study. J Nucl Med 1993;34:1467-1471.
7. Santana-Boado C, Candell-Riera J, Castell-Conesa J, Olona M, Palet-Balart J, Aguadé-Bruix S, García-Burillo A, Ortega-Alcalde D, Doménech-Torné FM, Soler-Soler J. Importancia de los parámetros ergométricos en los resultados de la tomogammagrafía de perfusión miocárdica. Med Clin (Barc) 1997;109:406-409.
8. Osbakken MD, Okada RD, Boucher CA, Strauss HW, Pohost GM. Comparison of exercise perfusion and ventricular function imaging: an analysis of factors affecting the diagnostic accuracy of each technique. J Am Coll Cardiol 1984;3:272-283.
9. Iqbal A, Gibbons RJ, Zinsmeister AR, Mock MB, Ballard DJ. Prognostic value of exercise radionuclide angiography in a population-based cohort of patients with known or suspected coronary artery disease. Am J Cardiol 1994;74:119-1124.
10. Laarman GJ, Bruschke AVG, Verzijlbergen FJ, Bal ET, Van der Wall EE, Ascoop CAPL. Efficacy of intravenous dipyridamole with exercise in thallium-201 myocardial perfusion scintigraphy. Eur Heart J 1988;9:1206-1214.
11. Laarman GJ, Bruschke AVG, Verzijlbergen JF, Go TL, Bal ET, Van der Wall EE, Ascoop CAPL. Thallium-201 scintigraphy after dipyridamole infusion with low level exercise. II. Quantitative analysis versus visual analysis. Eur Heart J 1990;11:162-172.
12. Laarman GJ, Serruys PW, Verzijlbergen JF, Ascoop CAPL. Thallium-201 scintigraphy after dipyridamole infusion with low-level exercise. III. Clinical significance and additional diagnostic value of ST segment depression and angina pectoris during the test. Eur Heart J 1990;11:705-711.
13. Ignaszewski AP, McCormick LX, Heslip PG, McEwan AJ, Humen DP. Safety and clinical utility of combined intravenous dipyridamole/symptom-limited exercise stress test with thallium-201 imaging in patients with known or suspected coronary artery disease. J Nucl Med 1993;34:2053-2061.
14. Casale PN, Guiney TE, Strauss HW, Boucher CA. Simultaneous low level treadmill exercise and intravenous dipyridamole stress thallium imaging. Am J Cardiol 1988;62:799-802.
15. Verzijbergen JF, Vermeersch PHMJ, Laarman GJ, Ascoop CAPL. Inadequate exercise leads to suboptimal imaging. Thallium-201 myocardial perfusion imaging after dipyridamole combined with low-level exercise unmasks ischemia in symptomatic patients with nondiagnostic thallium-201 scans who exercise submaximally. J Nucl Med 1991;32:2071-2078.
16. Stein L, Burt R, Oppenheim B, Schauwecker D, Fineberg N. Symptom-limited arm exercise increases detection of ischemia during dipyridamole tomographic thallium stress testing in patients with coronary artery disease. Am J Cardiol 1995;75:568-572.
17. Gibson RS, Beller GA, Gheorghiade M, Nygaard TW, Watson DD, Huey BL, Sayre SL, Kaiser DL. The prevalence and clinical significance of residual myocardial ischemia 2 weeks after uncomplicated non Q wave infarction: a prospective natural history study. Circulation 1986;73:1186-1198.
18. Brown KA, Weiss RM, Clements JP, Wackers FJ. Usefulness of residual ischemic myocardium within prior infarct zone for identifying patients at high risk late after acute myocardial infarction. Am J Cardiol 1987;60:15-19.
19. Gimple LW, Beller GA. Assessing prognosis after acute myocardial infarction in the thrombolytic era. J Nucl Cardiol 1994;1:198-209.
20. Dunn RF, Freedman B, Bailey IK, Uren R, Kelly DT. Noninvasive prediction of multivessel disease after myocardial infarction. Circulation 1980;62:726-734.
21. Patterson RE, Horowitz SF, Eng C, Meller J, Goldsmith SJ, Pichard AD, Halgash DA, Herman MV, Gorlin R. Can noninvasive exercise test criteria identify patients with left main or 3-vessel coronary disease after a first myocardial infarction? Am J Cardiol 1983;51:361-372.
22. Abraham RD, Freedman D, Dunn RF, Newman H, Roubin GS, Harris PJ, Kelly DT. Prediction of multivessel coronary artery disease and prognosis early after acute myocardial infarction by exercise electrocardiography and thallium-201 myocardial perfusion scanning. Am J Cardiol 1986;58:423-427.
23. Haber HL, Beller GA, Watson DD, Gimple LW. Exercise thallium-201 scintigraphy after thrombolytic therapy with or without angioplasty for acute myocardial infarction. Am J Cardiol 1993;71:1257-1261.
24. Castell-Conesa J, Santana-Boado C, Candell-Riera J, Aguadé Bruix S, Olona M, Canela T, García Burillo A, Gonzalez JM, Doménech Torné FM, Soler Soler J. La tomogammagrafía miocárdica de esfuerzo en el diagnóstico de la enfermedad coronaria multivaso. Rev Esp Cardiol 1997;50:635-642.
25. Laarman GJ, Niemeyer MG, Van der Wall EE, Verzijlbergen FJ, Go TL, Bruschke AVG, Ascoop CAPL. Dipyridamole thallium testing: noncardiac side effects, cardiac effects, electrocardiographic changes and hemodynamic changes after dipyridamole infusion with and without exercise. Int J Cardiol 1988;20:231-238.
26. Perper FJ, Segall GM. Safety of dipyridamole-thallium imaging in high risk patients with known or suspected coronary artery disease. J Nucl Med 1991;32:2107-2114.
27. Lette J, Tatum JI, Fraser S, Miller DD, Waters DD, Heller G, Satanton EB, Bom HS, Leppo J, Nattel S, for the Multicenter Dipyridamole Safety Study Investigators. Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study. J Nucl Cardiol 1995;2:3-17.